Sort
82,697 grants matching “vaccine development”
Development of Vaccines to Prevent Tuberculosis
$1,680,701Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Development of Vaccines to Prevent Tuberculosis
$1,680,146Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Mechanisms of Peripheral Induction of T-cell Tolerance
$1,679,927Kristin A. Hogquist · University Of Minnesota · P01 · FY2015 · AI
Mechanisms of Peripheral Induction of T-cell Tolerance
$1,679,927Matthew F Mescher · University Of Minnesota · P01 · FY2013 · AI
Immunotherapy of low grade lymphoid malignancies
$1,679,879Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Seattle Clinical Trials Unit
$1,679,850Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Mucosal Immunopathogenesis of Franscisella Tularensis
$1,679,845Dennis W. Metzger · Albany Medical College · P01 · FY2007 · AI
Mucosal Immunopathogenesis of Franscisella Tularensis
$1,679,625Dennis W. Metzger · Albany Medical College · P01 · FY2006 · AI
Nonhuman primate scientific research support component
$1,679,615Norman L Letvin · Duke University · UM1 · FY2013 · AI
Mechanisms of immune-mediated protection and pathogenesis during viral infections
$1,679,080Julie Fox · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Lifespan/Tufts/brown Center for AIDS Research (CFAR)
$1,678,852Susan Cu-Uvin · Miriam Hospital · P30 · FY2016 · AI
NCI-Frederick Support and Technical Services
$1,678,647Kristin Komschlies McConville · Office Of The Director, Nci · ZIC · FY2025 · CA
Preclinical Studies of Vaccines for Pandemic Influenza
$1,678,567Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$1,678,426Mark Fredric Cotton · Stellenbosch University · U01 · FY2007 · AI
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,678,283Marina Caskey · Rockefeller University · U01 · FY2019 · AI
Task V34: Master Cell Banks Manufacturing for Next Generation SARS-CoV-2 Vaccines
$1,678,100Heidi Trusheim · Idt Biologika Gmbh · N01 · FY2024 · AI
Building on the success of the adoptive immunotherapy of cancer
$1,677,370Nicholas P Restifo · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Nonhuman Primate Studies Coordination Center (NHP CC) to Support COVID-related Research at the National Primate Research Centers (NPRCs)
$1,676,937Jay Rappaport · Tulane University Of Louisiana · N01 · FY2021 · AI
Gut Homing Cells in SIV infection
$1,676,685Aftab A. Ansari · Emory University · R01 · FY2015 · AI
Developing Vaccine Candidates for the SARS Coronavirus
$1,676,513University Of North Carolina Chapel Hill · P01 · FY2005 · AI
NIAID Preclinical Development Support - Preclinical Toxicity Studies
$1,676,112Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
Development of a Vaccine for HIV-AIDS: Translation to the Clinic
$1,675,208Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$1,674,576Nelson Lee Michael · Walter Reed Army Institute Of Research · UM1 · FY2015 · AI
Philadelphia IMPAACT Clinical Trials Unit
$1,674,252Steven Daniel Douglas · Children'S Hosp Of Philadelphia · U01 · FY2008 · AI
Role of B Lymphocytes In HIV Infection And Pathogenesis
$1,674,241Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI